Inotek Collapses By 70% After Phase 3 Trial Disappoints
January 03, 2017 at 10:43 AM EST
Inotek Pharmaceuticals Corp (NASDAQ: ITEK) shares are trading lower by $4.27 at $1.83 in Tuesday's session. The catalyst for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.